147 related articles for article (PubMed ID: 22705145)
21. Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease.
Hov GG; Aasarød KI; Sagen E; Åsberg A
Clin Biochem; 2015 Jul; 48(10-11):646-51. PubMed ID: 25828044
[TBL] [Abstract][Full Text] [Related]
22. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L-arginine in patients with arteriogenic and non-arteriogenic erectile dysfunction.
Paroni R; Barassi A; Ciociola F; Dozio E; Finati E; Fermo I; Ghilardi F; Colpi GM; Corsi MM; Melzi d'Eril GV
Int J Androl; 2012 Oct; 35(5):660-7. PubMed ID: 22519580
[TBL] [Abstract][Full Text] [Related]
23. Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study.
Aucella F; Maas R; Vigilante M; Tripepi G; Schwedhelm E; Margaglione M; Gesualdo L; Boeger R; Zoccali C
Atherosclerosis; 2009 Dec; 207(2):541-5. PubMed ID: 19501358
[TBL] [Abstract][Full Text] [Related]
24. Elevation of serum asymmetrical and symmetrical dimethylarginine in patients with advanced glaucoma.
Javadiyan S; Burdon KP; Whiting MJ; Abhary S; Straga T; Hewitt AW; Mills RA; Craig JE
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):1923-7. PubMed ID: 22395885
[TBL] [Abstract][Full Text] [Related]
25. Effects of combined supplementation with B vitamins and antioxidants on plasma levels of asymmetric dimethylarginine (ADMA) in subjects with elevated risk for cardiovascular disease.
Schmitt B; Wolters M; Kressel G; Hülsmann O; Ströhle A; Kühn-Velten WN; Lichtinghagen R; Bub A; Barth SW; Stichtenoth DO; Hahn A
Atherosclerosis; 2007 Jul; 193(1):168-76. PubMed ID: 16876171
[TBL] [Abstract][Full Text] [Related]
26. Association of asymmetric dimethylarginine and endothelial dysfunction.
Böger RH
Clin Chem Lab Med; 2003 Nov; 41(11):1467-72. PubMed ID: 14656027
[TBL] [Abstract][Full Text] [Related]
27. Arginine and asymmetric dimethylarginine in puromycin aminonucleoside-induced chronic kidney disease in the rat.
Chen GF; Moningka NC; Sasser JM; Zharikov S; Cunningham M; Tain YL; Schwartz IF; Baylis C
Am J Nephrol; 2012; 35(1):40-8. PubMed ID: 22179117
[TBL] [Abstract][Full Text] [Related]
28. Asymmetric dimethylarginine is transported by the mitochondrial carrier SLC25A2.
Porcelli V; Longo A; Palmieri L; Closs EI; Palmieri F
Amino Acids; 2016 Feb; 48(2):427-36. PubMed ID: 26403849
[TBL] [Abstract][Full Text] [Related]
29. Serum reference intervals of homoarginine, ADMA, and SDMA in the study of health in Pomerania.
Atzler D; Schwedhelm E; Nauck M; Ittermann T; Böger RH; Friedrich N
Clin Chem Lab Med; 2014 Dec; 52(12):1835-42. PubMed ID: 24945429
[TBL] [Abstract][Full Text] [Related]
30. The combined ratios of L-arginine and asymmetric and symmetric dimethylarginine as biomarkers in spontaneously hypertensive rats.
Hsu CN; Huang LT; Lau YT; Lin CY; Tain YL
Transl Res; 2012 Feb; 159(2):90-8. PubMed ID: 22243793
[TBL] [Abstract][Full Text] [Related]
31. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.
Schulze F; Carter AM; Schwedhelm E; Ajjan R; Maas R; von Holten RA; Atzler D; Grant PJ; Böger RH
Atherosclerosis; 2010 Feb; 208(2):518-23. PubMed ID: 19700158
[TBL] [Abstract][Full Text] [Related]
32. Detrimental effect of oxidized LDL on endothelial arginine metabolism and transportation.
Zhang WZ; Venardos K; Finch S; Kaye DM
Int J Biochem Cell Biol; 2008; 40(5):920-8. PubMed ID: 18069040
[TBL] [Abstract][Full Text] [Related]
33. Asymmetric dimethylarginine concentrations decrease in patients with HIV infection under antiretroviral therapy.
Kurz K; Teerlink T; Sarcletti M; Weiss G; Zangerle R; Fuchs D
Antivir Ther; 2012; 17(6):1021-7. PubMed ID: 22892398
[TBL] [Abstract][Full Text] [Related]
34. Diagnostical significance of dimethylarginine in the development of hepatorenal syndrome in patients with alcoholic liver cirrhosis.
Nicković V; Nikolić J; Djindjić N; Ilić M; Nicković J; Mladenović D; Krstić N
Vojnosanit Pregl; 2012 Aug; 69(8):686-91. PubMed ID: 22924265
[TBL] [Abstract][Full Text] [Related]
35. High clinical accuracy of asymmetric dimethylarginine and symmetric dimethylarginine in patients with ischemic heart disease.
Djordjević BV; Pavlović R; Ćosić V; Deljanin-Ilić M; Ristić T; Krstić N; Jevtović-Stoimenov T
Amino Acids; 2012 Dec; 43(6):2293-300. PubMed ID: 22555650
[TBL] [Abstract][Full Text] [Related]
36. Rate of transport of l-arginine is independent of the expression of inducible nitric oxide synthase in HEK 293 cells.
Cui Z; Tuladhar R; Hart SL; Marber MS; Pearson JD; Baydoun AR
Nitric Oxide; 2005 Feb; 12(1):21-30. PubMed ID: 15631944
[TBL] [Abstract][Full Text] [Related]
37. Effects of coronary revascularization with or without cardiopulmonary bypass on plasma levels of asymmetric dimethylarginine.
Cziráki A; Ajtay Z; Németh Á; Lenkey Z; Sulyok E; Szabados S; Alotti N; Martens-Lobenhoffer J; Szabó C; Bode-Böger SM
Coron Artery Dis; 2011 Jun; 22(4):245-52. PubMed ID: 21383621
[TBL] [Abstract][Full Text] [Related]
38. Increased levels of symmetric dimethyl-arginine are associated with all-cause mortality in patients with symptomatic peripheral arterial disease.
Staniszewska A; Rajagopalan S; Al-Shaheen A; Thies F; Brittenden J
J Vasc Surg; 2015 May; 61(5):1292-8. PubMed ID: 25776186
[TBL] [Abstract][Full Text] [Related]
39. Antitumor effects of novel mAbs against cationic amino acid transporter 1 (CAT1) on human CRC with amplified CAT1 gene.
Okita K; Hara Y; Okura H; Hayashi H; Sasaki Y; Masuko S; Kitadai E; Masuko K; Yoshimoto S; Hayashi N; Sugiura R; Endo Y; Okazaki S; Arai S; Yoshioka T; Matsumoto T; Makino Y; Komiyama H; Sakamoto K; Masuko T
Cancer Sci; 2021 Feb; 112(2):563-574. PubMed ID: 33211385
[TBL] [Abstract][Full Text] [Related]
40. Cellular interactions between L-arginine and asymmetric dimethylarginine: Transport and metabolism.
Shin S; Thapa SK; Fung HL
PLoS One; 2017; 12(5):e0178710. PubMed ID: 28562663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
